For example, the well‐known genetic alterations that could evaluate the prognosis are inv(16) (p13q22) (CBFβ‐MYH11), t(8;21)(q22;q22) (AML1‐ETO) and mixed lineage leukemia rearrangements (MLL‐R). This evidence concerns the gene KMT2A and leukemia.